文献速递认知障碍与痴呆

临床前阿尔茨海默病的分子时间线:常染色体显性阿尔茨海默病为何重要

Molecular timeline of preclinical Alzheimers disease: why Autosomal Dominant Alzheimers Disease (ADAD) matters
RSS 订阅 · Journal of Neurology, Neurosurgery and Psychiatry

本文论述常染色体显性阿尔茨海默病(ADAD)因致病突变自受孕即存在,为研究因果事件与最早可检测表现之间的间隔提供了独特机会。Belder等利用这一自然实验,探讨临床前阿尔茨海默病的分子时间线,强调ADAD与散发性AD在时间推断上的差异。

要点

  • ADAD致病突变(APP/PSEN1)自受孕存在,但因果事件不等于最早可检测表现。
  • ADAD提供遗传锚定的自然实验,有助于界定临床前AD的分子时间线。
  • 散发性AD多过程汇聚,时间推断困难,ADAD可提供参照。

核心结论

  • ADAD因因果事件明确,可用于研究从致病突变到最早可检测生物学表现之间的间隔。

研究设计与样本

  • 本文为针对Belder等研究的评论/解读,利用ADAD作为人类神经退化的自然实验。

主要发现

  • ADAD中APP和PSEN1致病变异自受孕即存在,建立终生疾病易感性。
  • 因果事件与最早可检测的疾病表现不一定是同一现象。

临床怎么用

  • 在ADAD家系中关注从突变携带到可检测生物学标志物出现的时间窗,以界定临床前阶段。

局限性

  • 原文为评论/解读,未报告具体样本量、效应值或统计检验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

When the causal mutation is known, the challenge shifts from identifying disease origins to defining its detectable beginning. For decades, the study of Alzheimer’s disease has been framed by a deceptively simple question: when does the disease begin? In autosomal dominant Alzheimer’s disease (ADAD), the causal event is known. Pathogenic variants in amyloid precursor protein (APP) and presenilin 1 (PSEN1) are present from conception, establishing a lifelong predisposition to disease. Yet knowing the cause does not reveal when the disease becomes biologically manifest. The distinction is important: the causal event and the earliest detectable manifestation of disease are not necessarily the same phenomenon. ADAD offers a rare opportunity to investigate the interval between them. Belder et al 1 exploit one of the most informative natural experiments in human neurodegeneration. Unlike sporadic Alzheimer’s disease, where multiple biological processes converge and temporal inference remains challenging, ADAD provides a genetically anchored...

来源:Journal of Neurology, Neurosurgery and Psychiatry,查看原文。版权归原作者所有。

引用

  1. Journal of Neurology, Neurosurgery and Psychiatry:Molecular timeline of preclinical Alzheimers disease: why Autosomal Dominant Alzheimers Disease (ADAD) matters

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。